Rebound of weight gain following topiramate cessation [4]

Pharmacopsychiatry

Volumn 40, Issue 2, 2007, Pages 85-86

  Khazaal, Y ^a   Zullino, D F ^b  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TETRAHYDROLIPSTATIN; TOPIRAMATE;

ADULT; CASE REPORT; COGNITIVE THERAPY; DISTRESS SYNDROME; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; HUMAN; LETTER; MALE; NUTRITIONAL ASSESSMENT; OBESITY; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN; WITHDRAWAL SYNDROME;

ADULT; ANTI-OBESITY AGENTS; FEEDING BEHAVIOR; FRUCTOSE; HUMANS; MALE; OBESITY; SUBSTANCE WITHDRAWAL SYNDROME; WEIGHT GAIN;

EID: 34247869630     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970139     Document Type: Letter

References (6)

1. Balfour ME, Yu L, Coolen LM: Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology 2004; 29 (4): 718-730
2. Baptista T, Kin NM, Beaulieu S, de Baptista EA: Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Pharmacopsychiatry 2002; 35 (6): 205-219
3. Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M et al.: A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003; 11 (6): 722-733
4. Gibbs JW, III, Sombati S, DeLorenzo RJ, Coulter DA: Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000; 41 (Suppl 1): S10-S16
5. Jackson A, Mead AN, Stephens DN: Behavioural effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse. Pharmacol Ther 2000; 88 (1): 59-76
6. Rubio G, Ponce G, Jimenez-Arriero MA, Palomo T, Manzanares J, Ferre F: Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 2004; 37 (1): 37-40